Cargando…

Roxadustat: Do we know all the answers?

Anemia is a common complication of chronic kidney disease (CKD), and its prevalence rises as the disease progresses. Intravenous or subcutaneous erythropoiesis-stimulating agents (ESAs) are advised to treat CKD-associated anemia, since shortage of erythropoietin (EPO) and iron is the main cause of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiu-Yu, Xiong, Qian-Wen, Yao, Xuefeng, Liu, Fei, Tang, Xiaoxiao, Fu, Haidong, Tong, Tong, Mao, Jianhua, Peng, Wan-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171438/ https://www.ncbi.nlm.nih.gov/pubmed/36724056 http://dx.doi.org/10.17305/bb.2022.8437

Ejemplares similares

Glomerular diseases after immune checkpoint inhibitors use: What do We know so far?
por: He, Xue, et al.
Publicado: (2022)

Giant cell tumor - distal end radius: Do we know the answer?
por: Panchwagh, Yogesh, et al.
Publicado: (2007)

Chronic myeloid leukemia in children, do we have all the answers?
por: Bansal, Shweta
Publicado: (2014)

Surgical management of intermittent exotropia: do we have an answer for all?
por: Chougule, Pratik, et al.
Publicado: (2019)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

COVID-19—What we know and what we need to know: There are more questions than answers
por: Maisch, Bernhard, et al.
Publicado: (2020)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

The Role of the Microbiome in Autism: All That We Know about All That We Don’t Know
por: David, Maude M.
Publicado: (2021)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

All eyes on Coronavirus—What do we need to know as ophthalmologists
por: Khanna, Rohit C, et al.
Publicado: (2020)

Thymic epithelial tumors: Do we know all the prognostic factors?
por: Knetki‐Wróblewska, Magdalena, et al.
Publicado: (2021)

Bone-Targeted Agents in Breast Cancer: Do We Now Have All the Answers?
por: Ottewell, Penny, et al.
Publicado: (2019)

Obstructive Sleep Apnea and Right Ventricular Remodeling: Do We Have All the Answers?
por: Tadic, Marijana, et al.
Publicado: (2023)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022)

Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
por: Plaz Torres, Maria Corina, et al.
Publicado: (2019)

Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
por: Lin, Tong, et al.
Publicado: (2021)

What we know and do not know about women and kidney diseases; Questions unanswered and answers unquestioned: Reflection on World Kidney Day and International Woman’s Day
por: Piccoli, G.B., et al.
Publicado: (2018)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

Sodium and brain injury: do we know what we are doing?
por: Zygun, David A
Publicado: (2009)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

How little do we know?
por: Waslekar, Sundeep
Publicado: (2007)

Do we know the limits of the heart?
por: Figueras-Coll, Marc, et al.
Publicado: (2022)

Experimental subjects do not know what we think they know
por: Field, Jared M., et al.
Publicado: (2020)

Health Statistics in Australia: What We Know and Do Not Know
por: Madden, Richard, et al.
Publicado: (2022)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of Roxadustat
por: Czock, David, et al.
Publicado: (2021)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

IgA B Cell Responses to Gut Mucosal Antigens: Do We Know it all?
por: Lycke, Nils Y.
Publicado: (2013)

A Rare, Unreported Cognitive Side Effect of Topiramate: Do We Know It All Yet?
por: Karim, Nurose, et al.
Publicado: (2020)

What We Do and Do Not Know About Women and Kidney Diseases; Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Woman’s Day
por: Piccoli, Giorgina B., et al.
Publicado: (2018)

What We Do and Do Not Know about Women and Kidney Diseases: Questions Unanswered and Answers Unquestioned: Reflection on World Kidney Day and International Women's Day
por: Piccoli, G. B., et al.
Publicado: (2018)

What we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on World Kidney Day and International Woman’s Day
por: Piccoli, Giorgina B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vin4d4u6mdr5ro2962ivhf3oik